CSIMarket Company Name, Ticker, Suppliers, else..


Redhill Biopharma Ltd   (NASDAQ: RDHL)
Other Ticker:  
 

Redhill Biopharma Ltd

RDHL's Fundamental analysis



Redhill Biopharma Ltd 's sales fell by -89.43 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 338

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.85 %

Redhill Biopharma Ltd 's net profit decreased by -66.63 % in IV. Quarter 2023 year on year, to $24 millions.

• More on RDHL's Growth


Redhill Biopharma Ltd
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 11.55 in trailing twelve-month period.
Company
9.64
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 35.31.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.


• More on RDHL's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 272,083
 Net Income/Employee (TTM) $ 996,500
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.02

Redhill Biopharma Ltd
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 11.55 in trailing twelve-month period.
Company
9.64
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 35.31.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.

Redhill Biopharma Ltd Price to Book Ratio is at 111.43 higher than Industry Avg. of 79.76, and higher than S&P 500 Avg. of 0.01

• More on RDHL's Valuation

•  Market Capitalization (Millions $) 231
•  Shares Outstanding (Millions) 96
•  Employees 24
•  Revenues (TTM) (Millions $) 7
•  Net Income (TTM) (Millions $) 24
•  Cash Flow (TTM) (Millions $) 20
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 272,083
•  Net Income/Employee(TTM) $ 996,500
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 0.02

•  Market Capitalization (Millions $) 231
•  Shares Outstanding (Millions) 96
•  Employees 24
•  Revenues (TTM) (Millions $) 7
•  Net Income (TTM) (Millions $) 24
•  Cash Flow (TTM) (Millions $) 20
•  Capital Exp. (TTM) (Millions $) 0


    RDHL's Profitability Comparisons
Redhill Biopharma Ltd